Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text







Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Biomarkers
Chemical & Compound Analysis
Pharmacology
Novalix

Blog
Prof. Dr. Wagschal - What can we expect from the upcoming elections in Germany?
September 15, 2021
Read blog
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
PicnicHealth

Blog
Transformative Antibody Technology Brings Speed and Flexibility to Bioanalytical Assay Development
September 13, 2021
Sponsored by:
Sponsor
Read blog
Antibodies
In Vitro Assays
Chemistry, Manufacturing & Controls
Bio-Rad

Blog
Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine
September 2, 2021
Read blog
Biomarkers
Disease Models
Pharmacology
No items found.
Market Access
No items found.
Biomarkers
HBS
Discovery Life Sciences
Protein Sciences
Antibodies
In Vitro Assays
R&D Systems
Health Economics & Outcomes Research (HEOR)
No items found.
Disease Models
Louise Parr-Brownlie
Conor Underwood
ADInstruments
American Physiological Society
Disease Models
Hayley Crawford
Carl Marci
Integral Molecular
OM1
Scientist.com
HealthEconomics.com
Cell Culture & Characterization
Pharmacology
Vesna Posarac
Amanda Vanden Hoek
STEMCELL Technologies Inc.
Scientist.com
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Eric Benchimol
Karina Raimundo
Anil Vachani
Michael Broder
PHAR
HealthEconomics.com
Disease Models
Cell Culture & Characterization
Bioimaging
Joe Soughayer
Adam Veteto
IonOptix
No items found.
Real-World Evidence (RWE)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Eric Stanek
Michael Grabner
Deb Discenza
Jennifer Degl
Thomas F. Miller
HealthCore, Inc.
HealthEconomics.com
Pharmacology
HBS
Clinical Trials
Anuj Kalsy
Robert Snyder
Precision for Medicine
Scientist.com
Pharmacology
Discovery Chemistry
Chemical & Compound Analysis
Martin Slater
Cresset
Scientist.com

Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)

Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)

Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM

Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences































.avif)






